Real-world datasets for the International Registry for Alzheimer's Disease and Other Dementias (InRAD) and other registries: An international consensus.
Robert Perneczky, David Darby, Giovanni B Frisoni...
https://pubmed.ncbi.nlm.nih.gov/39971671/Actively Recruiting
Led by Stichting International Registry for Alzheimer's Disease and other Dementias Foundation · Updated on 2026-10-22
50000
Participants Needed
23
Research Sites
N/A
Total Duration
This international observational study focuses on people with Alzheimers disease PwAD to understand long-term disease outcomes and treatment safety. It collects real-world data from routine clinical practice at global centers. The study aims to assess disease progression, cognitive and functional changes, and the relationship between patient characteristics, treatments, and outcomes across different regions. Participants include adults undergoing diagnostic work-up for Alzheimers disease or already diagnosed, whether treated or untreated. The study is non-interventional, meaning no treatments are assigned by the study team. Data is collected through routine care visits at least once a year, with additional assessments or treatments offered as needed by their doctors. Data is entered via a secure web platform, including demographics, clinical outcomes, safety information, and treatment details. Participants visit their doctors regularly as part of their usual care. Researchers collect data on disease stages, cognition, safety events, and treatments over up to 10 years. Safety is monitored through recording adverse events using standardized coding. No financial reimbursement is provided, and treatment costs are covered by patients or their insurers. The study supports long-term follow-up and comparative research using pooled data from many global centers.
CONDITIONS
InRAD Observational Study
S
Scientific Officer
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
Lead Sponsor
InRAD Foundation (Data Processor)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 10 years
Participants visit their doctors regularly as part of routine care, at least annually or as needed. Data on disease progression, treatments, and safety events are collected during these visits over several years.
At least one visit per year
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Robert Perneczky, David Darby, Giovanni B Frisoni...
https://pubmed.ncbi.nlm.nih.gov/39971671/Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
Lead Sponsor
InRAD Foundation (Data Processor)
Collaborating Sponsor